Ganga Pharmaceuticals Ltd. - Research Center

---

Results

• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

4.06

4.06

4.06

4.06

4.06

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

1.39

1.35

1.31

1.29

1.09

Loan funds

Secured loans

1.83

1.81

1.56

1.44

1.41

Unsecured loans

-

-

-

0.01

0.46

Total

7.28

7.22

6.93

6.80

7.03

Uses of funds

Fixed assets

Gross block

1.35

1.33

1.32

1.30

1.29

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

0.71

0.65

0.60

0.54

0.49

Net block

0.64

0.68

0.72

0.76

0.80

Capital work-in-progress

-

-

-

-

-

Investments

0.09

0.09

0.09

0.09

0.09

Net current assets

Current assets, loans & advances

7.26

7.23

6.85

6.72

6.87

Less : current liabilities & provisions

0.71

0.77

0.73

0.76

0.73

Total net current assets

6.55

6.46

6.12

5.96

6.14

Miscellaneous expenses not written

-

-

-

-

-

Total

7.28

7.22

6.93

6.80

7.03

Notes:

Book value of unquoted investments

0.09

0.09

0.09

0.09

0.09

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

40.62

40.62

40.62

40.62

40.62